Related Experiment Video

Updated: Jun 2, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction

Carolyn Hoppe1, Frans Kuypers, Sandra Larkin

  • 1Department of Haematology/Oncology, Children's Hospital & Research Center Oakland, 747 52nd Street, Oakland, CA 94609, USA. choppe@mail.cho.org

British Journal of Haematology
|April 12, 2011
PubMed

Insights

Short-term simvastatin improved vascular function in sickle cell disease (SCD) patients by increasing nitric oxide metabolites and decreasing inflammation markers. This pilot study suggests simvastatin may offer a therapeutic benefit for SCD.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Sickle cell disease (SCD) involves vascular injury, similar to atherosclerosis.
  • Statins are known to reduce inflammation and improve endothelial function in cardiovascular disease.
  • The effects of statins on vascular dysfunction in SCD are currently unknown.

Purpose of the Study:

  • To evaluate the safety and efficacy of short-term simvastatin treatment in patients with SCD.
  • To assess the impact of simvastatin on biomarkers of vascular dysfunction in SCD.

Main Methods:

  • A pilot study involving 26 SCD patients treated with simvastatin (20 or 40 mg/d) for 21 days.
  • Analysis of plasma biomarkers including nitric oxide metabolites (NOx), C-reactive protein (CRP), and interleukin-6 (IL-6).
  • Comparison of treatment responses between low-dose and moderate-dose simvastatin groups.

Main Results:

  • Simvastatin significantly increased NOx levels in a dose-dependent manner (52% overall increase).
  • Simvastatin reduced CRP (68% overall decrease) and IL-6 levels.
  • No significant effect was observed on vascular endothelial growth factor (VEGF), vascular cell adhesion molecule-1 (VCAM-1), or tissue factor (TF).
  • Simvastatin was well-tolerated and demonstrated a good safety profile.

Conclusions:

  • Short-term simvastatin treatment appears safe and well-tolerated in SCD patients.
  • Simvastatin shows a potential therapeutic role in SCD by improving vascular function markers.
  • Preliminary findings suggest a dose-related effect on NOx, CRP, and IL-6 levels, warranting further investigation.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...